Kato, N <br/><br/>
Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats.  [electronic resource] 

 -  Diabetes research and clinical practice  Oct 2000 
 - 77-85 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0168-8227 
<br/><br/><label>Standard No.: </label>10.1016/s0168-8227(00)00164-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aldehyde Reductase--antagonists & inhibitors<br/>Animals<br/>Blood Glucose--metabolism<br/>Body Weight--drug effects<br/>Diabetes Mellitus, Experimental--pathology<br/>Diabetic Neuropathies--drug therapy<br/>Enzyme Inhibitors--therapeutic use<br/>Fructose--metabolism<br/>Glycated Hemoglobin--analysis<br/>Imidazoles--pharmacology<br/>Imidazolidines<br/>Inositol--metabolism<br/>Male<br/>Myelin Sheath--drug effects<br/>Nerve Fibers--drug effects<br/>Peripheral Nerves--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Sciatic Nerve--drug effects<br/>Sorbitol--metabolism<br/>Sural Nerve--drug effects<br/>Tibial Nerve--drug effects<br/>Time Factors